The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of ABBV-399, a c-Met antibody-drug conjugate (ADC), as monotherapy and in combination with erlotinib in patients (pts) with non-small cell lung cancer (NSCLC).
 
ERIC ANGEVIN
Consulting or Advisory Role - GlaxoSmithKline; Merck Sharp & Dohme
Research Funding - Abbvie (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Abbvie; Roche; Sanofi
 
John H. Strickler
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Celgene; Genentech/Roche; Onyx
Research Funding - Abbvie (Inst); Bayer (Inst); Exelixis (Inst); Gilead Sciences (Inst); MedImmune (Inst); OncoMed (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst)
 
Colin D. Weekes
Honoraria - Celgene; Lilly; Merrimack
Consulting or Advisory Role - Celgene; Merrimack
Research Funding - Abbvie; Bayer; Celgene; Genentech/Roche; Lilly; Millennium
 
Rebecca Suk Heist
Consulting or Advisory Role - ARIAD; Boehringer Ingelheim
Research Funding - Abbvie (Inst); Celgene (Inst); Debiopharm Group (Inst); Incyte (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Peregrine Pharmaceuticals (Inst); Roche (Inst); Takeda (Inst)
 
Daniel Morgensztern
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; Heat Biologics
Research Funding - AstraZeneca (Inst); Baxter (Inst); Celgene (Inst); Clovis Oncology (Inst); Heat Biologics (Inst); Incyte (Inst); Merck (Inst); Newlink Genetics (Inst); Stem CentRx (Inst)
 
John J. Nemunaitis
Employment - Gradalis
Leadership - Gradalis
Stock and Other Ownership Interests - Gradalis
Honoraria - Amgen; AstraZeneca
Consulting or Advisory Role - Amgen; AstraZeneca
Speakers' Bureau - Amgen; AstraZeneca
Patents, Royalties, Other Intellectual Property - Gradalis
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Baxalta; Takeda
 
Xiaolin Fan
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Juliette Beaulieu
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Monica Motwani
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Daniel E. Afar
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Louie Naumovski
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Karen Kelly
Honoraria - Bristol-Myers Squibb; Merck; Roche
Consulting or Advisory Role - ARIAD; ARIAD; AstraZeneca; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; G1 Therapeutics; Genentech/Roche; Lilly; Lilly; Synta
Research Funding - Abbvie (Inst); Celgene (Inst); EMD Serono (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Gilead Sciences (Inst); Lilly (Inst); Millennium (Inst); Novartis (Inst); Transgene (Inst)
Patents, Royalties, Other Intellectual Property - Author Royalties for UpToDate, an evidence based, peer reviewed information resource, available via the web, desktop, and PDA.
Travel, Accommodations, Expenses - ARIAD; AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Merck; Roche